Same Indication

Metformin vs Osimertinib

Metformin vs Osimertinib: Overview

This comparison examines the pharmacological differences between Metformin and Osimertinib.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Metformin β€” 4-9 hours; Osimertinib β€” 48 hours.

Chemical Properties

Molecular Formula: Metformin β€” C4H11N5; Osimertinib β€” C28H33N7O2.

Molecular Weight: Metformin β€” 129.1640 g/mol; Osimertinib β€” 499.6050 g/mol.

Type: Metformin β€” Small molecule; Osimertinib β€” Small molecule.